22 May 2013
Keywords: new, medimmune, coo, david, mott, becomes, president
Article | 20 November 1995
David Mott becomes president, chief operating officer and board
member at MedImmune.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
21 May 2013
© 2013 thepharmaletter.com